Table 4:

Outcomes by RIFLE classes (n = 951)

VariablesNo AKIRIFLE class RRIFLE class IRIFLE class FP-value*
Number of patients, n (%)666 (70)170 (18)58 (6)57 (6)
RRT, n (%)6 (0.9)9 (5.3)6 (10.4)54 (94.7)<0.0001
Mortality, n (%)10 (1.5)11 (6.5)10 (17.2)31 (54.4)<0.0001
Prolonged ventilationa, n (%)98 (14.9)47 (29.6)25 (52.1)17 (64.4)<0.0001
Hospital length of staya, days9.8 ± 8.4 median 814.6 ± 17.5 median 1018.6 ± 13.8 median 1534.2 ± 24.6 median 28<0.001
VariablesNo AKIRIFLE class RRIFLE class IRIFLE class FP-value*
Number of patients, n (%)666 (70)170 (18)58 (6)57 (6)
RRT, n (%)6 (0.9)9 (5.3)6 (10.4)54 (94.7)<0.0001
Mortality, n (%)10 (1.5)11 (6.5)10 (17.2)31 (54.4)<0.0001
Prolonged ventilationa, n (%)98 (14.9)47 (29.6)25 (52.1)17 (64.4)<0.0001
Hospital length of staya, days9.8 ± 8.4 median 814.6 ± 17.5 median 1018.6 ± 13.8 median 1534.2 ± 24.6 median 28<0.001

RRT: renal replacement therapy. Data are mean ± SD unless otherwise specified.

aData only given for patients without mortality.

*P-value regarding comparison over all three RIFLE classes.

Table 4:

Outcomes by RIFLE classes (n = 951)

VariablesNo AKIRIFLE class RRIFLE class IRIFLE class FP-value*
Number of patients, n (%)666 (70)170 (18)58 (6)57 (6)
RRT, n (%)6 (0.9)9 (5.3)6 (10.4)54 (94.7)<0.0001
Mortality, n (%)10 (1.5)11 (6.5)10 (17.2)31 (54.4)<0.0001
Prolonged ventilationa, n (%)98 (14.9)47 (29.6)25 (52.1)17 (64.4)<0.0001
Hospital length of staya, days9.8 ± 8.4 median 814.6 ± 17.5 median 1018.6 ± 13.8 median 1534.2 ± 24.6 median 28<0.001
VariablesNo AKIRIFLE class RRIFLE class IRIFLE class FP-value*
Number of patients, n (%)666 (70)170 (18)58 (6)57 (6)
RRT, n (%)6 (0.9)9 (5.3)6 (10.4)54 (94.7)<0.0001
Mortality, n (%)10 (1.5)11 (6.5)10 (17.2)31 (54.4)<0.0001
Prolonged ventilationa, n (%)98 (14.9)47 (29.6)25 (52.1)17 (64.4)<0.0001
Hospital length of staya, days9.8 ± 8.4 median 814.6 ± 17.5 median 1018.6 ± 13.8 median 1534.2 ± 24.6 median 28<0.001

RRT: renal replacement therapy. Data are mean ± SD unless otherwise specified.

aData only given for patients without mortality.

*P-value regarding comparison over all three RIFLE classes.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close